Galanin receptor subtypes as potential therapeutic targets

Bibliography

• TATEMOTO K, ROKAEUS A, JORNWALL H, MCDONALDTJ, MUTT V: Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett. 164:124–128 (1983).
   PubMed Web of Science ®Google Scholar
• BARTFAI T, HOKFELT T, LANGEL U: Galanin - a neuroen-docrine peptide. Grit. Rev. Neurobiol. (1993) 7:229–274.
   PubMed Web of Science ®Google Scholar
• CRAWLEY JN: Biological actions of galanin. RegulatoryPeptides (1995) 59:1–16.
   Google Scholar
• •Excellent review of the physiological roles of galanin.
   Google Scholar
• KASK K, BERTHOLD M, BARTFAI T: Galanin receptors: involvement in feeding, pain, depression and Alzheimer's disease. Life Sci. (1997) 60(18):1523–1533.
   PubMed Web of Science ®Google Scholar
• •Excellent review of the physiological roles of galanin.
   Google Scholar
• CRAWLEY JN: Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's dis-ease. Life ScL (1996) 58:2185–2199.
   PubMed Web of Science ®Google Scholar
• HABERT-ORTOLI E, AMIRANOFF B, LOQUET I, LABURTHE M, MAYAUX JF: Molecular cloning of a functional human galanin receptor. Proc. Natl. Acad. ScL USA (1994) 91:9780–9783.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the cloning and characterisation of thefirst galanin receptor, the GaIR1 receptor.
   Google Scholar
• BURGEVIN CM, LOQUET I, QUARTERONET D, HABERT-ORTOLI E: Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J. Mol. NeuroscL (1995) 6:33–41.
   PubMed Web of Science ®Google Scholar
• LORIMER DD, BENYA RV: Cloning and quantification of galanin-1 receptor expression by mucosal cells lining the human gastrointestinal tract. Biochem. Biophys. Res. Commun. (1996) 222:379–385.
   PubMed Web of Science ®Google Scholar
• PARKER EM, IZZARELLI DG, NOWAK HP et al.: Cloning and characterization of the rat GALR1 galanin receptor from Rinl4B insulinoma cells. Mol. Brain Res. (1995) 34:179–189.
   PubMedGoogle Scholar
• WANG S, HE C, MAGUIRE M et al.: Genomic organization and functional characterization of the mouse Ga1R1 galanin receptor. FEBS Lett. (1997) 411:225–230.
   PubMed Web of Science ®Google Scholar
• JACOBY AS, WEBB GC, LIU ML et al.: Structural organiza-tion of the mouse and human GALR1 galanin receptor genes (Galnr and GALNID and chromosomal localiza-tion of the mouse gene. Genomics (1997) 45(3)496–508.
   Google Scholar
• HOWARD AD, TAN C, SHIAO L-L et al.: Molecular cloning and characterization of a new receptor for galanin. FEBS Lett. (1997) 405:285–290.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the cloning and characterisation of theGa1R2 receptor.
   Google Scholar
• WANG S, HASHEMI T, HE C, STRADER C, BAYNE M: Molecular cloning and pharmacological characterization of a new galanin receptor. Mol. Pharmacol. (1997) 52:337–343.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the cloning and characterisation of theGa1R2 receptor.
   Google Scholar
• FATHI Z, CUNNINGHAM AM, IBEN LG et al.: Cloning, pharmacological characterization and distribution of a novel galanin receptor. Brain Res. Mol. Brain Res. (1997) 51(1-2):49–59.
   PubMedGoogle Scholar
• ••This paper describes the cloning and characterisation of theGa1R2 receptor.
   Google Scholar
• SMITH KE, FORRAY C, WALKER MW et al.: Expression cloning of a rat hypothalamic galanin receptor cou-pled to phosphoinositide turnover. J. Biol. Chem. (1997) 272:24612–24616.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the cloning and characterisation of theGa1R2 receptor.
   Google Scholar
• BLOOMQUIST BT, BEAUCHAMP MR, ZHELNIN L et al. Cloning and Expression of the Human Galanin Receptor Ga1R2. Biochem. Biophys. Res. Commun. (1998) 243 (2):474–479.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the cloning and characterisation of theGa1R2 receptor.
   Google Scholar
• WANG S, HE C, HASHEMI T, BAYNE M. Cloning and expressional characterization of a novel galanin recep-tor: identification of different pharmacophores within galanin for the three galanin receptor sub-types. J. Biol. Chem. (1997) 272:31949–31952.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the initial cloning and characterisationof the Ga1R3 receptor.
   Google Scholar
• PANG L, HASHEMI T, LEE H-J et al. The mouse Ga1R2 galanin receptor: genomic organization, cDNA cloning and functional characterization. J. Neurochem. (1998) (In Press)
   Google Scholar
• BARTFAI T, LANGEL U: Galanin receptor ligands as potential therapeutic agents in depression and neurode-generation. Eur. J. Med. Chem. (1 9 9 5) 30(Suppl.):s163–s174.
   Google Scholar
• •A good review of galanin receptor ligands.
   Google Scholar
• WANG S, GUSTAFSON E: Galanin receptor subtypes. Drug News Perspect. (1998). (In Press).
   Google Scholar
• LORIMER DD, MATKOWSKJ K, BENYA RV: Cloning, chro-mosomal location, and transcriptional regulation of the human galanin-1 receptor gene (GALN112). Bio-chem. Biophys. Res. Commun. (1997) 241(2):558–564.
   PubMed Web of Science ®Google Scholar
• CODY JD, HALE DE, BRKANAC Z, KAYE CI, LEACH RJ:Growth hormone insufficiency associated with hap-loinsufficiency at 18q23. Am. J. Merl. Genet. (1997) 71(4):420–425.
   PubMed Web of Science ®Google Scholar
• SAAR K, VALKNA A, SOOMETS U et al.: Role of the thirdcytoplasmic loop in signal transduction by galanin re-ceptors. Biochem. Soc. Trans. (1997) 25(3):1036–1040.
   PubMed Web of Science ®Google Scholar
• WANG S, CLEMMONS A, STRADER C, BAYNE M: Evidencefor hydrophobic interaction between galanin and the GalR1 galanin receptor and GalRl-mediated ligand in-ternalization: fluorescent probing with a fluorescein-galanin. Biochemistry (1998) 37(26):9528–9535.
   PubMed Web of Science ®Google Scholar
• KASK K, LANGEL U, BARTFAI T: Galanin - a neuropep-tide with inhibitory actions. Cell. Mol. Neurobiol (1995) 15(6)653–673.
   Google Scholar
• HEUILLET E, BOUAICHE Z, MENAGER J et al.: The humangalanin receptor: ligand-binding and functional char-acteristics in the Bowes melanoma cell line. Eur. Pharmacol. (1994) 269 (2) :139–147.
   PubMed Web of Science ®Google Scholar
• KASK K, BERTHOLD M, KAHL U, NORDVALL G, BARTFAIY: Delineation of the peptide binding site of the human galanin receptor. EMBO J (1996) 15:236–244.
   PubMed Web of Science ®Google Scholar
• •The first attempts to define the molecular mechanisms by which galanin binds to the Ga1R1 receptor.
   Google Scholar
• BERTHOLD M, KAHL U, JUREUS A et al: Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalRl. Eur. J. Biochem. (1997) 249:601–606.
   PubMedGoogle Scholar
• •The first attempts to define the molecular mechanisms by which galanin binds to the Ga1R1 receptor.
   Google Scholar
• WANG S, HASHEMI T, FRIED S, CLEMMONS AL, HAWES BE: Differential intracellular signaling of the Ga1R1 and Ga1R2 galanin receptor subtypes. Biochemistry (1998) 37(19):6711–6717.
   PubMed Web of Science ®Google Scholar
• GUSTAFSON EL, SMITH KE, DURKIN MM, GERALD C, BRANCHEK TA: Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport (1996) 7:953–957.
   PubMed Web of Science ®Google Scholar
• XU ZQ, SHI TJ, HOKFELT T: Expression of galanin and agalanin receptor in several sensory systems and bone analogue of rat embryos. Proc. Natl. Acad. ScL USA (1996) 93:14901–14905.
   PubMed Web of Science ®Google Scholar
• SULLIVAN KA, SHIAO LL, CASCIERI MA: Pharmacologicalcharacterization and tissue distribution of the human and rat GALR1 receptors. Biochem. Biophys. Res. Com-mun. (1997) 233(3):823–828.
   PubMed Web of Science ®Google Scholar
• VILLAR MJ, CORTES R, THEODORSSON E et al. Neuro-peptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with spe-cial reference to galanin. Neuroscience (1989) 33(3):587–604.
   PubMed Web of Science ®Google Scholar
• CALZA L, POZZA M, ZANNI M, MANZINI CU, MANZINI E, HOKFELT T: Peptide plasticity in primary sensory neu-rons and spinal cord during adjuvant-induced arthri-tis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience (1998) 82(2)575–589.
   Google Scholar
• XU ZQ, SHI TJ, LANDRY M, HOKFELT T: Evidence for gal-anin receptors in primary sensory neurones and ef-fect of axotomy and inflammation. Neuroreport (1996) 8(1)237–242.
   Google Scholar
• WALLI R, SCHAFER H, PAETZOLD M-W, NUSTEDE R, SCHMIDT WE: Identification and biochemical charac-terization of the human brain galanin receptor. J. Mol Endocrinol. (1994) 13:347–356.
   PubMed Web of Science ®Google Scholar
• STEN SHI TJ, ZHANG X, HOLMBERG K, XU ZQ, HOKFELTT: Expression and regulation of galanin-R2 receptors in rat primary sensory neurons: effect of axotomy and inflammation. Neurosci. Lett. (1997) 23 7 (2–3)57–60.
   Google Scholar
• DASCAL N, LIM NF, SCHREIBMAYER W, WANG W, DAVID-SON N, LESTER HA: Expression of an atrial G-protein-activated potassium channel in Xenopusoocytes. Proc. Natl. Acad. ScL USA 90(14):6596–6600 (1993).
   Google Scholar
• JUREUS A, LANGEL U, BARTFAI T: L-Ala-substituted ratgalanin analogs distinguish between hypothalamic and jejunal galanin receptor subtypes. J. Pept. Res. (1997) 49:195–200.
   PubMedGoogle Scholar
• YANAIHARA N, MOCHIZUKI T, TAKATSUKA N et al.: Gal-anin analogues: agonist and antagonist. Regulat. Pept. (1993) 46:93–101.
   PubMed Web of Science ®Google Scholar
• KAKUYAMA H, MOCHIZUKI T, IGUCHI K et al.: [A1a6,D-Trp8]Galanin(1-15)ol is a potent galanin antagonist on insulin release. Biomed. Res. (1997) 1:49–56.
   Google Scholar
• POOGA M, JUREUS A, RAZAEI K et al.: Novel galanin re-ceptor ligands. j Pept. Res. (1998) 51(1):65–74.
   PubMedGoogle Scholar
• LAND T, LANGEL U, LOW M, BERTHOLD M, UNDEN A,BARTFAI T: Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor. Int. J. PepL Protein Res. (1991) 38:267–272.
   PubMedGoogle Scholar
• CHUM, MIERZWA R, TRUUMEES I et al: A new fungal metabolite, SC11202596, with inhibitory activity in the gal-anin receptor GALR1 assay. Tetra. Lett. (1997) 38:6111–6114.
   Web of Science ®Google Scholar
• ••This paper describes the only known non-peptide galaninreceptor ligand.
   Google Scholar
• BARTFAI T: Galanin-A neuropeptide with importantcentral nervous system actions. In: Psychopharmacol-ogy: The Forth Generation of Progress. Bloom FE, Kupfer DJ (Eds.), Raven Press, New York, USA (1995):563–571.
   Google Scholar
• CORWIN RL, ROBINSON JK, CRAWLEY JN: Galanin an-tagonists block galanin-induced feeding in the hypo-thalamus and amygdala of the rat. Eur. J. NeuroscL (1993) 5(10:1528–1533.
   PubMed Web of Science ®Google Scholar
• CRAWLEY JN: Functional interactions of galanin andacetylcholine: relevance to memory and Alzheimer's disease. Behav. Brain Res. (1993) 57(2):133–141.
   PubMed Web of Science ®Google Scholar
• MARSH DJ, HOLLOPETER G, KAFER KE, PALMITER RD: Role of the Y5 neuropeptide Y receptor in feeding and obesity [see comments]. Nature Med. (1998) 4 (6):718–721.
   PubMed Web of Science ®Google Scholar
• PEDRAZZINI T, SEYDOUX J, KUNSTNER P et al: Cardio-vascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor [see com-ments]. Nature Med. (1998) 4(6)722–726.
   Google Scholar
• LAGNY-POURMIR I, AMIRANOFF B, LORINET AM, TATE-MOTO K, LABURTHE M: Characterization of galanin re-ceptors in the insulin-secreting cell line Rin m5F: evidence for coupling with a pertussis toxin-sensitive quanosine triphosphate regulatory protein. Endocri-nology (1989) 124:2635–2641.
   PubMed Web of Science ®Google Scholar
• LEONHARDT U, SIEGEL EG, KOHLER H et al. Galanin in-hibits glucose-induced insulin release in vitro. Horm. Metab. Res. (1989) 21(2):100–101.
   PubMed Web of Science ®Google Scholar
• MUFSON EJ, COCHRAN E, BENZING W, KORDOWER JH:Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia (1993) 4(5):237–250.
   PubMedGoogle Scholar
• ROBINSON JK, CRAWLEY JN: The role of galanin incholinergically-mediated memory processes. Prog. Neuropsychopharmacol. Biol. PsychiaL (1993) 17(1)71–85.
   Google Scholar
• MCDONALD MP, WILLARD LB, WENK GL, CRAWLEY JN: Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatch-ing to position choice accuracy in rats with choliner-gic lesions. J. Neurosci. (1998) 18(13):5078–5085.
   PubMed Web of Science ®Google Scholar
• CRAWLEY JN, ROBINSON JK, LANGEL U, BARTFAI T: Gal-anin receptor antagonists M40 and Cl block galanin-induced feeding. Brain Res. (1993) 600:268–272.
   PubMed Web of Science ®Google Scholar
• WIESENFELD-HALLIN Z, XU XJ, LANGEL U, BEDECS K, HOKFELT T, BARTFAI T: Galanin-mediated control of pain: enhanced role after nerve injury. Proc. Natl. Acad. ScL USA (1992) 89(8):3334–3337.
   PubMed Web of Science ®Google Scholar
• WYNICK D, SMITH D, GHATEI M et al.: Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc. Natl. Acad. Sci. USA (1993) 90:4231–4235.
   PubMed Web of Science ®Google Scholar
• KENAKIN TP: The relative contribution of affinity and efficacy to agonist activity: organ selectivity of nora-drenaline and oxymetazoline with reference to the classification of drug receptors. Br. J. Pharmacol. (1984) 81(1):131–141.
   PubMed Web of Science ®Google Scholar